Independence Bank of Kentucky reduced its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 4.0% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16,925 shares of the biopharmaceutical company’s stock after selling 705 shares during the period. Independence Bank of Kentucky’s […]
Stonebridge Capital Management Inc. cut its holdings in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 2.4% during the 2nd quarter, HoldingsChannel reports. The fund owned 28,605 shares of the biopharmaceutical company’s stock after selling 700 shares during the quarter. Stonebridge Capital Management Inc.’s holdings in Bristol-Myers Squibb were worth $1,829,000 at the end […]
Douglass Winthrop Advisors LLC increased its position in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 20.8% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 47,265 shares of the biopharmaceutical company’s stock after buying an additional 8,150 shares during the period. Douglass Winthrop […]
Edgar Lomax Co. VA decreased its position in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 16.8% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 127,765 shares of the biopharmaceutical company’s stock after selling 25,750 shares during the quarter. Edgar Lomax […]
Crewe Advisors LLC lowered its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 2.7% in the first quarter, according to its most recent 13F filing with the SEC. The fund owned 11,067 shares of the biopharmaceutical company’s stock after selling 309 shares during the period. Crewe Advisors LLC’s holdings in Bristol-Myers Squibb […]